Eurofins Central Laboratory Expands US Lab Operations to PA Campus - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Eurofins Central Laboratory Expands US Lab Operations to PA Campus

Source: Applied Clinical Trials

Eurofins Central Laboratory announced the expansion and relocation of its US Central Laboratory Operations to the company's 330,000 square foot Pharma Services campus in Lancaster, PA. The consolidation of the company's Central Laboratory with its Lancaster Laboratories comes amongst the recently announced acquisitions of US bioanalytical, discovery, genomic and diagnostic laboratories. The purpose built Central Laboratory is essential to the global footprint of wholly-owned laboratory facilities in the United States, Europe, Asia and China.

Read the full release here.

 

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here